Treating children with cancer requires a strong blood supply; donations critically needed

VUMC awarded CDC funding to combat antimicrobial resistance, infectious diseases

Vanderbilt has partnered with the CDC to combat the crisis of antimicrobial resistance and other healthcare threats through a newly created Global Action in Healthcare Network (GAIHN).

Potential Rett syndrome drug shows promising results in phase 3 trial

A potential first-of-its-kind drug to treat the symptoms of Rett syndrome received positive top-line results from a phase 3 trial led by investigators from Vanderbilt University Medical Center to evaluate efficacy and safety.

VUMC mourns loss of pediatric immunology expert Lawton

Alexander R. “Sandy” Lawton III, MD, emeritus professor of Pediatrics, died earlier this fall at 82.

VKC data shows increase in autism spectrum disorder prevalence, provides new data on 4-year-olds

Vanderbilt Kennedy Center (VKC) researchers are seeing an increase in the number of children in Tennessee with autism spectrum disorder (ASD).

VUMC researchers involved in developing Moderna’s COVID-19 vaccine featured in Smithsonian exhibit

Researchers at Vanderbilt University Medical Center who contributed to the development of Moderna’s COVID-19 vaccine are featured in a new exhibit at the Smithsonian Institution in Washington, D.C.